Company / Interest Expense per Share
Processa Pharmaceuticals, Inc. Interest Expense per Share History
FY2013-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2021
5-year range
-$0.01 / $0.03
FY2017-FY2021
Trend
-7.3%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.03 to $0.02 over the past 6 years.
Based on SEC 10-K filings.
0.02 in FY2021 with a 5-year CAGR of -1.5%.
Improved from $0.03 to $0.02 over the past 6 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -1.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense per share decreased 7.3% year-over-year.
- Peak interest expense per share was recorded in FY2015.
- Lowest interest expense per share in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | $0.02 | -7.3% |
| FY2016 | $0.02 | -25.7% |
| FY2015 | $0.03 | +312.0% |
| FY2014 | -$0.01 | +85.3% |
| FY2013 | -$0.09 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026